Equities research analysts predict that Safeguard Scientifics, Inc (NYSE:SFE) will report earnings of ($0.56) per share for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Safeguard Scientifics’ earnings. Safeguard Scientifics reported earnings of $1.56 per share in the same quarter last year, which would indicate a negative year over year growth rate of 135.9%. The firm is expected to issue its next quarterly earnings results on Thursday, October 24th.
On average, analysts expect that Safeguard Scientifics will report full-year earnings of $1.71 per share for the current year. For the next year, analysts anticipate that the business will post earnings of ($1.60) per share. Zacks’ earnings per share calculations are an average based on a survey of research analysts that that provide coverage for Safeguard Scientifics.
Safeguard Scientifics (NYSE:SFE) last announced its earnings results on Thursday, August 8th. The asset manager reported $1.75 EPS for the quarter, beating the consensus estimate of ($0.85) by $2.60.
Shares of NYSE SFE opened at $11.03 on Monday. Safeguard Scientifics has a 12 month low of $7.98 and a 12 month high of $12.91. The company has a market cap of $221.19 million, a price-to-earnings ratio of -14.51 and a beta of 0.85. The company has a quick ratio of 1.97, a current ratio of 1.97 and a debt-to-equity ratio of 0.02. The business has a fifty day simple moving average of $11.73 and a 200-day simple moving average of $11.73.
Hedge funds and other institutional investors have recently made changes to their positions in the company. Captrust Financial Advisors lifted its holdings in shares of Safeguard Scientifics by 272.3% during the second quarter. Captrust Financial Advisors now owns 3,008 shares of the asset manager’s stock valued at $36,000 after purchasing an additional 2,200 shares during the last quarter. Campbell & CO Investment Adviser LLC purchased a new stake in shares of Safeguard Scientifics during the third quarter valued at $115,000. Spears Abacus Advisors LLC purchased a new stake in shares of Safeguard Scientifics during the second quarter valued at $202,000. Morgan Stanley lifted its holdings in shares of Safeguard Scientifics by 15.2% during the second quarter. Morgan Stanley now owns 19,979 shares of the asset manager’s stock valued at $241,000 after purchasing an additional 2,630 shares during the last quarter. Finally, NJ State Employees Deferred Compensation Plan lifted its stake in Safeguard Scientifics by 4.6% in the 2nd quarter. NJ State Employees Deferred Compensation Plan now owns 22,833 shares of the asset manager’s stock worth $275,000 after acquiring an additional 1,000 shares in the last quarter. 67.98% of the stock is owned by institutional investors and hedge funds.
Safeguard Scientifics Company Profile
Safeguard Scientifics, Inc no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round.
Read More: What is a Special Dividend?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Safeguard Scientifics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics and related companies with MarketBeat.com's FREE daily email newsletter.